References
- Lambert T. Olanzapine after clozapine: the rare case of prolongation of granulocytopenia [letter]. Australian and New Zealand Journal of Psychiatry 1998; 32: 591–592
- Flynn S W, Altman S, MacEwan G W, Black L L, Greenidge L L, Honer W G. Prolongation of clozapine-induced granulocytopenia associated with olanzapine. Journal of Clinical Psychopharmacology 1997; 17: 494–495
- Chengappa K N, Gopalani A, Haught M K, McChesney K, Baker R W, Schooler N R. The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF). Psychopharmacology Bulletin 1996; 32: 111–121
- Gerson S L, Gullion G, Yeh H S, Masor C. Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis [letter]. Lancet 1992; 340: 1097
- Atkin K, Kendall F, Gould D, Freeman H, Liberman J, O'Sullivan D. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. British Journal of Psychiatry 1996; 169: 483–488
- Gardner I, Leeder S, Chin T, Zahid N, Uetrecht J P. A comparison of the covalent binding of clozapine and olanzapine to human neutrophils in vitro and in vivo. Molecular Pharmacology 1998; 53: 999–1008
- Gardner I, Zahid N, MacCrimmon D, Uetrecht J P. A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leucocytes. Molecular Pharmacology 1998; 53: 991–998